MYLAN I 400 (Imatinib Mesylate 400 mg)

Pill with imprint MYLAN I 400 is Orange, Elliptical/Oval and has been identified as Imatinib Mesylate 400 mg. It is supplied by Mylan Pharmaceuticals Inc.

Imatinib is used in the treatment of chronic myelogenous leukemia; dermatofibrosarcoma protuberans; chronic eosinophilic leukemia; acute lymphoblastic leukemia; gastrointestinal stromal tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN I 400

Imatinib Mesylate

Imprint: MYLAN I 400
Strength: 400 mg
Color: Orange
Size: 19.00 mm
Shape: Elliptical/Oval
Availability: Prescription only
Drug Class: BCR-ABL tyrosine kinase inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: Mylan Pharmaceuticals Inc.
National Drug Code (NDC): 00378-2246
Inactive Ingredients: silicon dioxide, magnesium stearate, microcrystalline cellulose, ferric oxide red, magnesium silicate, titanium dioxide, ferric oxide yellow
Note: Inactive ingredients may vary.